So pre-pilot technology not well enough piloted or was it all hype?
Another one bites the dust.
Three comments here:
Addison Lawrence was not a commercial shrimp farmer but a University professor – so while easy to grow shrimp in laboratory small scale with top heavy labour relative to cost output – not necessarily a scale-able technology. Thought his patent was for stacked tanks – perhaps project would work if it were not for…
….Biofloc – dominate and manage a culture to culture the shrimp…hmmm. Tricky – which is why clearwater may be a better RAS method (automated) and more cost effective. Nust managing bioflic one is not managing shrimp culture and by the time one looks at shrimp….woooosh…too late.
All shrimp viruses can be managed with good husbandry and that means feed and water quality.
Having a system in quarantine should mean that one can carry receiving seed and growing the shrimp out in commercial production. If quarantine and contained no risk then is there! So only sufferance will be if poor husbandry and poor shrimp performance. It becomes a commercial problem. Just that biofloc does not work with RAS.
Importance of marketing and appropriate sales must not be underestimated – its not just growing at good production cost but also selling at good enough price.
Harnessing big data to fight shrimp diseases and allay investor fears…..
First drum up the fear to apply apparent solution.
Solution being good husbandry, quality input products, no anti-biotics.
Overblown in relation to target farmer audience….and end consumers……however sustainability at all levels of industry wellcome.
Prawnmaster wishes narrative moves on from disease (to more pressing problems). Quality assurance and regulatory compliance.
Oh, and growing demand.
Definition of (shrimp) aquaculture.
Semi-intensive in shrimp farming is with additional feed and with pumping. Here Bob explains.
IDH could do with some clarity in their work.
Go here to see IDH definition….download investment guideline Indonesia
BCG on Indonesia – again some nice info-matics. Technology in intensification and health, genetics, feed is ongoing in the industry globally but goes hand-in-hand with growing demand. Prices are at all time lows. Production intensification and associated shrimp farming technology has been growing y-o-y for 35 years now – its a gentle ramp up and industry is leading. There is nothing disruptive or especially singular but a measured response to demand.
End users and major players buying out of Indonesia already do have traceability and sustainability programs with exporters. There are plenty of CB’s with programs in Indonesia. ACC, ASC, GlobalGAP, etc, etc.
Of course things get murky when one buys to secondary process – you know like additives, breading, cooking, meal kits, etc – as many do European secondary processors. As vannamei is a commodity product it can be interchanged easily – subject to minimal food safety import requirements.
Trace-ability is for marketing (apart from standard country trade requirements). Honestly a meal served to a hospital or other service is looking for cheapest shrimp. Volumes mean no end consumer visuals in food-service – unlike retail.
Of course picture of cigala from Scotland. Gamba roja from Denia is the shellfish that hit €200+